Association between hypercoagulability and decreased survival in horses with ischemic or inflammatory gastrointestinal disease.

The research article explores the connection between hypercoagulability (HC), a condition where the blood clots excessively, and decreased survival rates in horses suffering from ischemic or inflammatory gastrointestinal diseases. In the study, they found evidence supporting this association, although the diagnostic techniques for HC need to be improved.

Overview of the Research

The research in question is an observational clinical study carried out with 90 horses in total: 30 horses suffering from ischemic or inflammatory gastrointestinal (GI) disease, 30 horses with non-ischemic or inflammatory GI disease, and 30 healthy horses serving as the control group.

The objectives of this study were to investigate:

• The occurrence of HC in horses with ischemic or inflammatory GI diseases
• The correlation between the degree of HC and the related complications including non-survivability

Research Methodologies

The research incorporated a prospective approach, where they conducted advanced testing in the form of thromboelastography (TEG) to determine the coagulation profiles of these horses. Testing was done on admission and again 48 hours afterward. The test results from the diseased horses were then compared to the profiles of healthy horses.

Additionally, the team conducted more traditional coagulation testing to cross-verify the presence of HC. This incorporated measuring aspects such as:

• Prothrombin time (PT) which is the time taken for the blood to clot
• Activated partial thromboplastin time (aPTT) which tests the functionality of blood clotting factors
• Antithrombin activity (AT), as antithrombin is a protein that helps control blood clotting
• D-Dimer concentrations, a protein fragment from the breakdown of a blood clot

Key Findings

Upon analyzing the results, the researchers discovered that horses with ischemic or inflammatory GI disease demonstrated shorter R times compared to the healthy horses. R time is a measure obtained through TEG and it represents the time taken for the initial formation of a blood clot. Shorter R time often indicates HC, suggesting a higher risk of thrombotic complications.

However, the research identified that the TEG profiles of horses with GI diseases did not strongly point towards hypercoagulability compared to prior studies on both animals and humans. The conventional testing also showed evidence of hypercoagulability with decreased AT and increased D-Dimer concentrations.

Interestingly, the results from TEG and conventional testing methods did not overlap often, meaning that both the TEG profiles and the coagulation abnormalities were not detected in the same horses. Hence, they were not statistically related.

Conclusions and Future Directions

Ultimately, the study provides evidence pointing to the existence of HC in horses with ischemic or inflammatory GI diseases. However, the current techniques used for diagnosing HC require refinement. This suggests a need for more accurate diagnostic methods to confirm the presence of HC in horses thoroughly and to devise more effective measures for managing related health risks.